ARTICLE | Regulation
Going green: what pharmas promise on the environment
With climate disclosures a looming issue for all public companies, big pharma’s emissions goals provide benchmarks for the industry
January 24, 2023 10:49 PM UTC
Against the backdrop of imminent SEC rules that could require climate disclosures for all publicly traded companies, pharma ESG reports provide a snapshot of what environmental priorities and goals can look like. How smaller companies could adapt these goals to their own scale and priorities remains to be seen.
While environmental reporting rules would require many pre-revenue biotechs to build compliance capacity from scratch, voluntary climate disclosures have been a regular part of big pharma’s reporting for years. ...